Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of GFR Using Iohexol in Critically Ill Patients With Augmented Renal Clearance
NCT04776486Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2020
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of iohexol in augmented renal clearance (ARC), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Glomerular Filtration Rate obtained by the iohexol clearance technique at 6 hours and Glomerular Filtration Rate obtained by the creatinine clearance technique at 6 hours. Started Sep 2020; status: completed.
02
Drugs
iohexol
03
Conditions
augmented renal clearance (ARC)
Beyond the preview
Go deeper on NCT04776486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04776486.